Paul Chaney
Founder at PanOptica, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Guyer | M | 64 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York.
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ.
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | 24 years |
| Brian Strem | M | 44 | 3 years | |
| Melissa Tosca | F | 44 | 2 years | |
| Praveen Tyle | M | 64 | 16 years | |
| Sean McDonald | M | 63 |
Ocugenix Corp.
 Ocugenix Corp. Medical/Nursing ServicesHealth Services Ocugenix Corp. operates as a therapeutics company focusing on he development of of cancer immunotherapy drug for eye diseases. The company is headquartered in Pittsburgh, PA. | 9 years |
| Erin Parsons | F | 48 | 2 years | |
| David Hollander | M | 50 | 3 years | |
| Kenneth Gayron | M | 54 | 3 years | |
| Aron Shapiro | M | 46 | 3 years | |
| Carmine Stengone | M | 48 | 1 years | |
| Lori E. Forrest | F | - |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | - |
| Martin B. Wax | M | - |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | 15 years |
| Manfred Zoltobrocki | M | - |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | - |
| Kristine Curtiss | F | - |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | - |
| Thomas Dyrberg | M | 69 |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | - |
| David P. Bingaman | M | - |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | - |
| Richard Kollender | M | 54 |
Ocugenix Corp.
Ocugenix Corp. Medical/Nursing ServicesHealth Services Ocugenix Corp. operates as a therapeutics company focusing on he development of of cancer immunotherapy drug for eye diseases. The company is headquartered in Pittsburgh, PA. | - |
| Bruce Peacock | M | 72 |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | 9 years |
| Colin Goddard | M | 64 |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | 13 years |
| Eric Daniels | M | 51 | 3 years | |
| Thomas C. Hohman | M | - |
Ocugenix Corp.
Ocugenix Corp. Medical/Nursing ServicesHealth Services Ocugenix Corp. operates as a therapeutics company focusing on he development of of cancer immunotherapy drug for eye diseases. The company is headquartered in Pittsburgh, PA. | - |
| Michael Ross | M | 75 |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen From | M | 60 | 17 years | |
| Robert van Nostrand | M | 67 | 21 years | |
| Richard Fitzgerald | M | 60 | 2 years | |
| Abbie Celniker | M | 65 | 7 years | |
| Thomas Cannell | M | 62 | 5 years | |
| Jay Duker | M | 66 | 8 years | |
| Mark Sullivan | M | 52 | 5 years | |
| Wendy Dixon | M | 68 | 6 years | |
| Stephen Allen Hurly | M | 56 | 2 years | |
| Cary Pfeffer | M | 61 | 7 years | |
| Bernard Malfroy-Camine | M | 71 | 9 years | |
| Cameron Wheeler | M | 45 | - | |
| John McLaughlin | M | 72 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | - |
| Thomas Balland | M | 46 | - | |
| John J. McCabe | M | 57 | 5 years | |
| Leah Monteiro | F | - | - | |
| David Berry | M | 47 | 7 years | |
| Michael Patane | M | 59 | - | |
| Marty Glick | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | - |
| Thomas Hancock | M | 60 | 14 years | |
| Morton F. Goldberg | M | 86 | 13 years | |
| Gregory P. Adams | M | - | - | |
| Michael Meluzio | M | - | - | |
| Ley Smith | M | 90 |
The Upjohn Co.
| 39 years |
| Barry Gertz | M | 72 | - | |
| Noubar Afeyan | M | 60 | 6 years | |
| Susan Drexler | F | 54 | - | |
| Franz Obermayr | M | 55 | 1 years | |
| Mark Levin | M | 73 | 6 years | |
| Sarah Romano | F | 44 | 6 years | |
| Keith Westby | M | 49 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 3 years |
| Eric S. Furfine | M | 64 | 6 years | |
| Evelyn Harrison | F | - |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 6 years |
| Clay T. Cramer | M | - |
The Upjohn Co.
| 13 years |
| Mike Garanzini | M | - | - | |
| Mounia Chaoui-Roulleau | M | 52 | 3 years | |
| David Brooks | M | - | - | |
| Greg Zarbis-Papastoitsis | M | - | 6 years | |
| Carol Assang | F | - | - | |
| Shauna M. Tholen | F | - | 3 years | |
| Lee Arnold | M | 64 | 4 years | |
| Barbara Wirostko | M | 58 | - | |
| Lisa Brandano | F | - | - | |
| Ryan R. Brenneman | M | 62 | - | |
| Jennifer Burstein | F | 52 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 4 years |
| Karen L. Tubridy | M | 61 | 3 years | |
| Michael H. Goldstein | M | 57 | 2 years | |
| G. Morgan Browne | M | 89 | 14 years | |
| Glen C. MacDonald | M | 66 | - | |
| Michael P. Manzo | M | 64 | 15 years | |
| Peter R. Seaver | M | 81 |
The Upjohn Co.
| 31 years |
| Pablo Cagnoni | M | 60 | 3 years | |
| Christopher Carroll | M | 57 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 1 years |
| Walter M. Lovenberg | M | 89 | 15 years | |
| Neil Gibson | M | 67 | 6 years | |
| Gregory Perry | M | 63 | 1 years | |
| Bill O'Connor | M | 64 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 6 years |
| Joseph T. Kennedy | M | 56 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| Enrique Dilone | M | 57 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 4 years |
| Joseph Klein | M | 62 | 4 years | |
| Santo Costa | M | 78 | 4 years | |
| Mark P. Richmond | M | 92 | 7 years | |
| David Epstein | M | 65 | 7 years | |
| Glenn Sblendorio | M | 68 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 3 years |
| Dawn Viveash | M | 68 |
The Upjohn Co.
| 3 years |
| Leslie Lewis Dan | M | 94 | 3 years | |
| Clare M. Carmichael | F | 64 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| Emmett Cunningham | M | 63 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 4 years |
| Loni da Silva | F | - |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 5 years |
| Illya Keith Maher | M | 56 | 1 years | |
| Robert Gallotto | M | 59 |
The Upjohn Co.
| 8 years |
| Peter Greenleaf | M | 54 | 2 years | |
| Gary Jay Sternberg | M | - | 2 years | |
| Barrett Katz | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| Arthur P. DeCillis | M | 68 | 1 years | |
| Paul Fitzhenry | M | 64 |
The Upjohn Co.
| 7 years |
| Steven Boyd | M | 43 | 3 years | |
| Angela Dentiste | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul Chaney
- Personal Network
